14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $15.81 $21.68 Friday, 3rd May 2024 GH stock ended at $18.88. This is 1.61% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.81% from a day low at $18.73 to a day high of $19.63.
90 days $15.81 $23.36
52 weeks $15.81 $41.06

Historical Guardant Health Inc. prices

Date Open High Low Close Volume
May 03, 2024 $19.10 $19.63 $18.73 $18.88 1 003 329
May 02, 2024 $18.59 $18.68 $17.99 $18.58 926 814
May 01, 2024 $18.01 $18.97 $17.85 $18.26 1 126 320
Apr 30, 2024 $17.90 $18.33 $17.61 $18.00 883 987
Apr 29, 2024 $17.52 $18.38 $17.52 $18.19 1 306 456
Apr 26, 2024 $16.98 $17.52 $16.78 $17.35 682 749
Apr 25, 2024 $17.71 $17.85 $16.95 $17.16 1 647 185
Apr 24, 2024 $17.72 $18.11 $17.37 $18.10 1 582 198
Apr 23, 2024 $17.46 $18.26 $17.30 $17.34 1 783 933
Apr 22, 2024 $16.78 $17.68 $16.78 $17.59 1 920 118
Apr 19, 2024 $16.56 $16.79 $15.81 $16.07 1 854 920
Apr 18, 2024 $16.34 $16.84 $16.07 $16.67 1 536 287
Apr 17, 2024 $16.23 $16.88 $15.90 $16.39 1 464 525
Apr 16, 2024 $16.84 $16.89 $16.04 $16.16 1 845 802
Apr 15, 2024 $18.34 $18.45 $16.94 $17.06 2 371 219
Apr 12, 2024 $18.42 $18.58 $17.96 $18.26 1 283 564
Apr 11, 2024 $19.35 $19.41 $18.32 $18.68 1 042 802
Apr 10, 2024 $18.29 $19.21 $18.02 $19.11 1 676 293
Apr 09, 2024 $18.75 $19.86 $18.75 $19.20 1 918 224
Apr 08, 2024 $17.61 $18.80 $17.59 $18.66 2 042 150
Apr 05, 2024 $18.05 $18.30 $17.57 $17.63 2 438 357
Apr 04, 2024 $19.86 $20.12 $18.13 $18.15 3 648 445
Apr 03, 2024 $20.76 $21.68 $19.54 $19.70 3 154 734
Apr 02, 2024 $22.25 $22.56 $19.62 $20.79 6 329 468
Apr 01, 2024 $20.70 $20.70 $19.36 $20.25 2 004 127
Click to get the best stock tips daily for free!

About Guardant Health Inc.

Guardant Health. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test fo... GH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT